SORRENTO THERAPEUTICS INC (SRNE)

Shanghai Escugen Biotechnology Co., Ltd., a partner of Levena Biopharma, a Sorrento Company, releases positive results from a first-in-human study of ESG401, a TROP2 Antibody Drug Conjugate in patients with locally advanced/metastatic solid tumors at the

CHICAGO, June 05, 2023 (GLOBE NEWSWIRE) -- Shanghai Escugen Biotechnology Co., Ltd. (“Escugen”), a partner of Levena (Suzhou) Biopharma Co., Ltd....

Why Shares of Scilex Slumped This Week

A stock sale and confusion regarding its parent company are factors dragging down the stock.

Why Sorrento Therapeutics Stock Crashed Today

Any euphoria after the biotech stock's big jump yesterday didn't last long.

Meta Platforms Layoffs 2023: Are More Facebook Job Cuts Coming?

Meta Platforms (META) layoffs are a hot topic on Wednesday as reports spread that the Facebook parent company is planning more job cuts.

Alphabet Layoffs 2023: What to Know About the Latest Google Job Cuts

Alphabet (GOOGL,GOOG) layoffs are worth checking on Wednesday as recent reports claim Google job cuts are coming to Ireland.

The $75 Million Reason Sorrento (SRNE) Stock Is Moving Today

SRNE stock is moving this morning after soaring about 25% yesterday. The company recently declared bankruptcy after losing a lawsuit.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to watch on Wednesday morning!

Sorrento Therapeutics surges 28% as court nods for a $75M loan

U.S. Bankruptcy Court for the Southern District of Texas granted interim approval to Sorrento Therapeutics (SRNE) for $75M debtor-in-possession financing from JMB Capital Partners.This...

Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 Case

/PRNewswire/ -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to...

Why Shares of Sorrento Therapeutics Are Up Today

The company is walling off subsidiary Scilex from its bankruptcy proceedings.

Sorrento Posts Form 8937 to Supplement its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock (Nasdaq: SCLX, “Scilex”)

SAN DIEGO, Feb. 18, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today posted an IRS Form 8937 (the “Form 8937”) to...

Sorrento Issues Update to its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock (Nasdaq: SCLX, “Scilex”)

SAN DIEGO, Feb. 17, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today posted an update to its previously issued...

Interesting SRNE Call Options For April 21st

Sorrento Therapeutics, Inc. Receives Court Approval for "First Day" Employee Wages and Cash Management Motions

/PRNewswire/ -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to...

Joint Statement by Sorrento Therapeutics, Inc. and Scilex Holding Company on Today’s Isolated Chapter 11 Filing By Sorrento Therapeutics, Inc.

SAN DIEGO and PALO ALTO, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), a majority-owned subsidiary of...

5 Investors Betting Big on Sorrento Therapeutics (SRNE) Stock

SRNE stock is plummeting lower after the company disclosed that it had filed for Chapter 11 bankruptcy protection.

Hot Stocks: TDC climbs on earnings; FSLY upgrade; TWLO restructuring; SRNE bankruptcy

TDC rose on earnings news. FSLY climbed on an analyst upgrade. TWLO advanced on a restructuring program. SRNE plunged following a bankruptcy filing.

Why Sorrento Therapeutics Stock Is Crashing Today

A bankruptcy filing is weighing on the drugmaker's shares today.